Phase 2
N=134
Effectiveness of Preurodynamic With Posturodynamic Levofloxacin on the Incidence of UTI
Urinary Tract Infections
Bottom Line
View on ClinicalTrials.gov: NCT05219877 ↗Enrolled (actual)
134
Serious AEs
1.5%
Results posted
Nov 2023
Primary outcome: Primary: Number of Participant With Urinary Tract Infection — 12; 13 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Pre-urodynamic Levofloxacin (Drug); Post-urodynamic Levofloxacin (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Indonesia University
- Primary completion
- Apr 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participant With Urinary Tract Infection |
12; 13 | — |
Summary
This study aims to compare the effectiveness of preoperative single dose of levofloxacin with postoperative levofloxacin for three days on the incidence of urinary tract infections (UTI) after urodynamic examination.
Eligibility Criteria
Inclusion Criteria
- Male/female patients > 18 years who have indications for urodynamics
- Willing to participate in research
Exclusion Criteria
- Allergy to levofloxacin
- History of taking antibiotics in 1 month • Pregnant
- Uncontrolled DM
- Use a urinary catheter
- Having a UTI before urodynamics, based on clinical symptoms and urine examination results
- Refuse to participate in research
Data sourced from ClinicalTrials.gov (NCT05219877). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.